Zidovudine and the Natural History of the Acquired Immunodeficiency Syndrome

1991 ◽  
Vol 324 (20) ◽  
pp. 1412-1416 ◽  
Author(s):  
Richard D. Moore ◽  
Julia Hidalgo ◽  
Barbara W. Sugland ◽  
Richard E. Chaisson
1987 ◽  
Vol 24 (2) ◽  
pp. 169-176 ◽  
Author(s):  
Hugh C. Kim ◽  
Kenneth Nahum ◽  
Karel Raska ◽  
David J. Gocke ◽  
Martin Kosmin ◽  
...  

1986 ◽  
Vol 136 (5) ◽  
pp. 1162-1162
Author(s):  
B. Safai ◽  
K.G. Johnson ◽  
P.L. Myskowski ◽  
B. Koziner ◽  
S.Y. Yang ◽  
...  

1989 ◽  
Vol 86 (6) ◽  
pp. 771-775 ◽  
Author(s):  
Charles C.J. Carpenter ◽  
Kenneth H. Mayer ◽  
Alvan Fisher ◽  
Manish B. Desai ◽  
Linda Durand

2019 ◽  
Vol 7 ◽  
pp. 2050313X1982961
Author(s):  
Connie Zhang ◽  
Megan A Sander

A 58-year-old woman from Zimbabwe, with a history of untreated human immunodeficiency virus, presented with leonine facies and a diffuse rash. The rash occurred in the context of a 1-year history of constitutional symptoms and cognitive decline. Laboratory investigations confirmed that her human immunodeficiency virus had progressed to acquired immunodeficiency syndrome. Through imaging, tissue biopsies, and polymerase chain reaction, a diagnosis of disseminated histoplasmosis was made. Since there was no history of travel and histoplasmosis is not locally endemic, the patient likely contracted this fungal infection more than 7 years ago, while living in Africa. We speculate that the histoplasmosis remained latent until her immune system began to decline. The work-up and management of this rare cutaneous presentation of a systemic disease, which should be added to the list of “great mimickers” in dermatology, are discussed.


2021 ◽  
pp. 197-212
Author(s):  
Quarraisha Abdool Karim ◽  
Urisha Singh ◽  
Cheryl Baxter ◽  
Salim S. Abdool Karim

This chapter traces the history of human immunodeficiency virus (HIV) from its origins, remarkable scientific advances, and unprecedented global responses through to the current state of the epidemic, progress towards ending acquired immunodeficiency syndrome (AIDS) and remaining challenges. It explains the origins of HIV-1 and HIV-2, the development of a surveillance system, and the viral structure. It outlines different antiretroviral drugs used in the treatment of HIV infections, and current drug research. The prevention of both mother-to-child transmission and sexual transmission is outlined, including pre-exposure prophylaxis (PrEP) use. The development of modern technologies and social media to help people living with HIV is covered. Programmes to modify behaviour and reduce risk from injecting drug use are explained.


Sign in / Sign up

Export Citation Format

Share Document